课题基金 / 基金详情

Bedside to bench resources for lower urinary tract research

Bedside to bench resources for lower urinary tract research
用于下尿路研究的床边到工作台资源
批准号:
10705120
负责人:
Douglas William Strand
金额:
$102.72万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-15 至 2027-05-31
关键词:
ATAC-seqAdrenergic AntagonistsAlgorithmsAllelesAmino AcidsAntibodiesAutomobile DrivingBenign Prostatic HypertrophyBindingBladderBladder DysfunctionC-terminalCell NucleusCellsClinicalClinical DataComputer softwareDataData SetDatabasesDevelopmentDiseaseElderlyElderly manEngineeringEnsureEnterobacteria phage P1 Cre recombinaseExposure toFAIR principlesFibroblastsFrequenciesFunctional disorderGene ExpressionGenesGeneticGenetic TranscriptionGenomicsHumanImageIn SituIndividualJointsKnock-outLabelLinkLower urinary tractMedicalMethodsMolecularMouse StrainsMultiomic DataMusMutationMyofibroblastN-terminalNational Institute of Diabetes and Digestive and Kidney DiseasesObstructionOperative Surgical ProceduresOrganOrgan DonorOxidoreductasePathway AnalysisPatientsPharmaceutical PreparationsPopulationProcessProstateProstaticProstatic UrethraProtocols documentationReportingResearchResearch PersonnelResolutionResourcesResponse ElementsSmooth MuscleSpecificitySpecimenStreamStromal CellsSystemTestingTetracyclinesTherapeuticTissue BanksTissuesTrans-ActivatorsTransgenic MiceUrethraUrineValidationVisualizationage effectagedalpha-adrenergic receptorbench to bedsidebiobankcell typecombinatorialcomputational pipelinesdata centersdata resourcegenome annotationgenome browsergenomic locusgenomic predictorshistological stainshuman datahuman diseasehuman tissueimprovedinducible Creinhibitorinsightinteinmalemenmouse modelopen sourceoverexpressionpromoterprostate enlargementrational designselective expressionsingle cell analysissingle-cell RNA sequencingsynergismtherapeutic targettissue resourcetooltraittranscription factorurinary

项目摘要

项目成果

Douglas William Strand的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lower urinary tract dysfunction (LUTD) is a constellation of human-reported urinary indications, including urgency, intermittent and weak urinary stream, incomplete bladder emptying, and increased voiding frequency. A major cause of male LUTD is benign prostatic hyperplasia (BPH), which is medically managed with five alpha reductase inhibitors or alpha-adrenergic receptor antagonists. Neither drug reduces symptomatic progression by more than 34% and most of these elderly men have no option but surgery. Prostatic obstruction of urine flow can lead to bladder detrusor overactivity (DO), a poorly understood disease with largely ineffective therapeutic options. The medical management of LUTS due to prostate and bladder dysfunction has seen little improvement over the past 40 years because we have failed to capture the cell type-specific molecular alterations that would provide actionable therapeutic targets. This proposal will address fundamental barriers to deriving molecular mechanisms of human LUTD. In Aim 1 we will produce multi-omic data on cell type-specific molecular changes in human LUTD. We will link the data to a tissue repository managed with OpenSpecimen software, giving researchers searchable access to >3,000 clinically annotated normal and diseased human specimens. In Aim 2 we will engineer new mouse strains to achieve Cre expression in specific bladder, urethra, and prostate stromal cells. It is not possible with existing mouse strains to overexpress or knockout a gene in a bladder stromal cell without introducing the same genetic change in prostate and urethra, or vice versa. Accordingly, the unique contributions of prostate and bladder to urinary voiding cannot be isolated. We will overcome this problem by creating new mouse strains with selective inducible Cre expression in fibroblasts and smooth muscle. Finally, we will ensure that all resources are FAIR (Findable, Accessible, Interoperable, and Reusable) by incorporating all methods, tools, data and protocols into the NIDDK ATLAS Data Center. The proposed resources are significant because they establish foundational bedside to bench resources to generate and test hypotheses about LUTD mechanisms in human tissues and rationally designed mouse models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bedside to bench resources for lower urinary tract research
  • 批准号:
    10517227
  • 项目类别:
  • 资助金额:
    $103.93万
  • 财政年份:
    2022
  • 负责人:
    Douglas William Strand
  • 依托单位:
Notch-mediated 5ARI resistance in human BPH
  • 批准号:
    10413136
  • 项目类别:
  • 资助金额:
    $37.35万
  • 财政年份:
    2018
  • 负责人:
    Douglas William Strand
  • 依托单位:
Notch-mediated 5ARI resistance in human BPH
  • 批准号:
    10183238
  • 项目类别:
  • 资助金额:
    $37.86万
  • 财政年份:
    2018
  • 负责人:
    Douglas William Strand
  • 依托单位:
Interplay Between Stem Cells and Inflammation in Benign Prostatic Hyperplasia
  • 批准号:
    9166471
  • 项目类别:
  • 资助金额:
    $8.1万
  • 财政年份:
    2016
  • 负责人:
    Douglas William Strand
  • 依托单位:
海外基金